https://agenfarma.it/ hourly 1.0 https://agenfarma.it/farmaci/ daily 0.8 https://agenfarma.it/ricerca/ daily 0.8 https://agenfarma.it/sanita/ daily 0.8 https://agenfarma.it/ssn/ daily 0.8 https://agenfarma.it/prevenzione/ daily 0.8 https://agenfarma.it/salute/ daily 0.8 https://agenfarma.it/chi-siamo/ monthly 0.3 https://agenfarma.it/contatti/ monthly 0.3 https://agenfarma.it/privacy/ monthly 0.3 https://agenfarma.it/carenza-farmaci-farmacisti-comunitari-pronti-a-intervenire-ma-il-governo-uk/ 2026-10-19T03:31:05.047Z weekly 0.7 https://agenfarma.it/satralizumab-nuova-approvazione-fda-per-la-malattia-oculare-tiroidea/ 2026-10-17T06:02:39.928Z weekly 0.7 https://agenfarma.it/screening-per-il-cancro-cervicale-in-aumento-negli-usa-ma-persistono-disparita/ 2026-10-17T06:01:42.313Z weekly 0.7 https://agenfarma.it/malattia-infiammatoria-intestinale-e-riproduzione-assistita-gravidanza-nel-73/ 2026-10-16T20:02:53.003Z weekly 0.7 https://agenfarma.it/fda-via-libera-a-brytly-il-primo-collirio-otc-per-il-rossore-oculare/ 2026-10-16T20:01:58.095Z weekly 0.7 https://agenfarma.it/sequel-med-tech-s-twiist-system-receives-fda-approval-for-insulin-treated-type/ 2026-10-16T20:01:22.160Z weekly 0.7 https://agenfarma.it/attivita-fisica-nei-giovani-effetti-modesti-sui-rischi-cardiometabolici/ 2026-10-16T16:01:45.366Z weekly 0.7 https://agenfarma.it/tumore-al-pancreas-ema-approva-daraxonrasib-sopravvivenza-raddoppiata/ 2026-10-16T13:15:58.345Z weekly 0.7 https://agenfarma.it/animali-quando-la-morte-di-un-animale-pesa-piu-di-qualsiasi-altro-lutto-lifeanimal/ 2026-10-16T11:03:44.173Z weekly 0.7 https://agenfarma.it/esofagite-eosinofila-tezepelumab-raggiunge-la-remissione-istologica-nel-trial/ 2026-10-16T05:01:11.039Z weekly 0.7 https://agenfarma.it/daraxonrasib-nuova-terapia-orale-per-il-tumore-al-pancreas-approvazione-ema/ 2026-10-15T21:16:23.111Z weekly 0.7 https://agenfarma.it/uk-la-mhra-potenzia-gli-avvisi-sui-suicidi-legati-agli-antidepressivi/ 2026-10-15T19:01:09.701Z weekly 0.7 https://agenfarma.it/epcoritamab-risposta-rapida-nel-linfoma-follicolare-recidivante-negativita-mrd/ 2026-10-15T16:01:53.926Z weekly 0.7 https://agenfarma.it/teneligliptin-migliora-il-controllo-glicemico-nel-diabete-di-tipo-2-risultati/ 2026-10-15T05:01:30.950Z weekly 0.7 https://agenfarma.it/fda-amplia-l-uso-di-anktiva-con-bcg-per-il-carcinoma-della-vescica/ 2026-10-14T19:02:55.626Z weekly 0.7 https://agenfarma.it/colite-ulcerosa-nuova-terapia-orale-mostra-risultati-promettenti/ 2026-10-14T19:02:10.963Z weekly 0.7 https://agenfarma.it/editing-genomico-verso-la-chirurgia-del-dna-la-nuova-frontiera-delle-malattie/ 2026-10-14T13:02:47.318Z weekly 0.7 https://agenfarma.it/cannabis-medica-e-insonnia-benefici-limitati-e-aumento-degli-eventi-avversi/ 2026-10-14T13:02:02.766Z weekly 0.7 https://agenfarma.it/dermatite-atopica-un-nuovo-anticorpo-trispecifico-riduce-prurito-e-lesioni/ 2026-10-13T13:02:38.978Z weekly 0.7 https://agenfarma.it/amiloidosi-cardiaca-via-libera-in-scozia-al-nuovo-farmaco-rna/ 2026-10-13T13:01:56.259Z weekly 0.7 https://agenfarma.it/cancro-al-seno-localmente-avanzato-la-biopsia-del-linfonodo-sentinella-potrebbe/ 2026-10-13T05:31:15.332Z weekly 0.7 https://agenfarma.it/malattia-di-lyme-risultati-promettenti-dal-nuovo-vaccino-pediatrico/ 2026-10-12T12:03:12.846Z weekly 0.7 https://agenfarma.it/optimum-terapia-continua-stratificata-per-rischio-migliora-la-sopravvivenza-nel/ 2026-10-12T12:02:28.224Z weekly 0.7 https://agenfarma.it/artrite-reumatoide-farmaci-biologici-e-rischio-di-infezioni-lo-studio/ 2026-10-12T12:01:43.045Z weekly 0.7 https://agenfarma.it/care-for-running-artemisia-porta-la-sanita-tra-le-persone/ 2026-10-11T16:40:10.868Z weekly 0.7 https://agenfarma.it/carcinoma-mammario-oligometastatico-l-ablation-metastasi-diretta-non-migliora/ 2026-10-09T17:31:28.310Z weekly 0.7 https://agenfarma.it/morte-all-ospedale-cisanello-dopo-ore-di-attesa-ceccardi-attacca-la-toscana-sulla-sanita-pisana/ 2026-10-08T11:33:46.915Z weekly 0.7 https://agenfarma.it/malattia-epatica-steatosica-safe-score-guida-il-rischio-di-cirrosi-e-hcc/ 2026-10-08T05:31:30.138Z weekly 0.7 https://agenfarma.it/vitiligine-ritlecitinib-mostra-risultati-positivi-in-due-studi-di-fase-3/ 2026-10-07T19:31:30.140Z weekly 0.7 https://agenfarma.it/alopecia-areata-ritlecitinib-mostra-risultati-promettenti-a-lungo-termine/ 2026-10-06T19:31:35.004Z weekly 0.7 https://agenfarma.it/sclerosi-multipla-ocrelizumab-aumenta-il-rischio-di-infezioni-negli-anziani/ 2026-10-06T16:02:34.402Z weekly 0.7 https://agenfarma.it/mieloma-multiplo-iberdomide-supera-bortezomib-in-combinazione-con-daratumumab/ 2026-10-06T16:01:50.543Z weekly 0.7 https://agenfarma.it/prostata-piu-efficace-la-combinazione-con-arpi-rispetto-al-docetaxel/ 2026-10-06T16:01:11.211Z weekly 0.7 https://agenfarma.it/carcinoma-adrenocorticale-vivere-in-aree-contaminate-peggiora-la-sopravvivenza/ 2026-10-06T12:31:11.258Z weekly 0.7 https://agenfarma.it/sanita-lombarda-15-presenze-nel-ranking-newsweek-2027/ 2026-10-06T12:21:38.275Z weekly 0.7 https://agenfarma.it/medicina-olistica-titolo-honoris-causa-per-la-docente-luana-stortoni/ 2026-10-06T09:58:28.898Z weekly 0.7 https://agenfarma.it/pirtobrutinib-approvato-dalla-fda-per-cll-sll-in-prima-linea/ 2026-10-05T16:32:31.380Z weekly 0.7 https://agenfarma.it/artrite-reumatoide-refrattaria-blinatumomab-a-basso-dosaggio-potrebbe-resettare/ 2026-10-05T16:31:48.714Z weekly 0.7 https://agenfarma.it/fibromi-uterini-confronto-tra-ablazione-laparoscopica-e-miomectomia/ 2026-10-05T12:31:39.017Z weekly 0.7 https://agenfarma.it/nice-approva-olezarsen-per-l-ipertrigliceridemia-familiare/ 2026-10-05T12:31:03.008Z weekly 0.7 https://agenfarma.it/psoriasi-icotrokinra-mostra-efficacia-duratura-nelle-aree-ad-alto-impatto-fino/ 2026-10-05T05:01:51.701Z weekly 0.7 https://agenfarma.it/terapia-radiante-con-piastrelle-di-cesio-131-risultati-promettenti-nel/ 2026-10-04T19:01:15.964Z weekly 0.7 https://agenfarma.it/psoriasi-a-placche-zasocitinib-supera-deucravacitinib-nello-studio-latitude/ 2026-10-04T15:31:20.598Z weekly 0.7 https://agenfarma.it/prurigo-nodularis-risultati-positivi-per-un-nuovo-anticorpo-monoclonale/ 2026-10-04T04:32:05.065Z weekly 0.7 https://agenfarma.it/hidradenite-suppurativa-nuove-terapie-biologiche-mostrano-risultati-promettenti/ 2026-10-04T04:31:18.062Z weekly 0.7 https://agenfarma.it/avelumab-nel-carcinoma-a-cellule-di-merkel-metastatico-nuovi-dati-dal-mondo/ 2026-10-03T15:01:48.411Z weekly 0.7 https://agenfarma.it/inghilterra-vaccino-antinfluenzale-gratuito-per-i-senzatetto-parte-la-campagna/ 2026-10-03T11:02:03.066Z weekly 0.7 https://agenfarma.it/lupus-cutaneo-daxdilimab-riduce-significativamente-l-attivita-della-malattia-i/ 2026-10-03T11:01:03.827Z weekly 0.7 https://agenfarma.it/retina-piu-sottile-prima-della-diagnosi-un-nuovo-segnale-precoce-per-il-diabete/ 2026-10-03T04:02:37.616Z weekly 0.7 https://agenfarma.it/car-t-nelle-malattie-autoimmuni-sospensione-degli-studi-dopo-tre-decessi/ 2026-10-03T04:01:46.606Z weekly 0.7 https://agenfarma.it/meningite-b-allarme-in-inghilterra-solo-il-26-6-dei-giovani-vaccinati/ 2026-10-02T11:03:08.873Z weekly 0.7 https://agenfarma.it/palmoplantar-pustulosis-upadacitinib-mostra-segni-di-efficacia-in-uno-studio-di/ 2026-10-02T11:02:21.863Z weekly 0.7 https://agenfarma.it/diabete-di-tipo-2-orforglipron-mostra-risultati-promettenti-negli-esiti/ 2026-10-02T04:02:32.932Z weekly 0.7 https://agenfarma.it/vitiligine-upadacitinib-migliora-l-efficacia-fino-a-76-settimane/ 2026-10-02T04:01:54.322Z weekly 0.7 https://agenfarma.it/iniezione-sperimentale-elimina-fino-al-12-del-grasso-viscerale-i-risultati-del/ 2026-10-02T04:01:13.274Z weekly 0.7 https://agenfarma.it/semaglutide-e-perdita-di-massa-muscolare-trevogrumab-mostra-risultati/ 2026-10-02T00:16:04.611Z weekly 0.7 https://agenfarma.it/cardio-race-artemisia-lab-protagonista-della-tre-giorni-dedicata-alla-salute/ 2026-10-01T14:31:28.568Z weekly 0.7 https://agenfarma.it/cancro-al-pancreas-sbrt-e-chemioradioterapia-a-confronto-risultati-simili-ma/ 2026-10-01T12:02:31.644Z weekly 0.7 https://agenfarma.it/diabete-e-farmaci-cardioprotettivi-il-ruolo-del-sesso-e-dello-stato/ 2026-10-01T12:01:47.471Z weekly 0.7 https://agenfarma.it/trapianto-renale-negli-anziani-la-malattia-arteriosa-periferica-predice-la/ 2026-10-01T12:01:04.923Z weekly 0.7 https://agenfarma.it/rocca-piu-risorse-per-gli-stipendi-del-personale-sanitario-e-maggiore-autonomia/ 2026-10-01T10:16:17.649Z weekly 0.7 https://agenfarma.it/surpass-cvot-tirzepatide-riduce-la-mortalita-non-cardiovascolare-rispetto-a/ 2026-10-01T05:02:26.092Z weekly 0.7 https://agenfarma.it/retatrutide-risultati-promettenti-nella-perdita-di-peso-per-pazienti-con/ 2026-10-01T05:01:45.070Z weekly 0.7 https://agenfarma.it/dupilumab-e-allergie-alimentari-aumentano-le-reazioni-nelle-sfide-orali/ 2026-09-30T19:01:10.904Z weekly 0.7 https://agenfarma.it/cancro-uroteliale-ct-e-citologia-non-sostituiscono-l-ureteroscopia-nel-follow-up/ 2026-09-30T15:33:01.028Z weekly 0.7 https://agenfarma.it/disturbi-della-differenziazione-epidermica-crescita-compromessa-nei-primi-due/ 2026-09-30T15:32:16.156Z weekly 0.7 https://agenfarma.it/copd-l-arginina-e-vitamina-c-migliorano-la-fatica-durante-la-riabilitazione/ 2026-09-30T15:31:33.381Z weekly 0.7 https://agenfarma.it/diabete-giovanile-aumentano-i-casi-di-tipo-1-e-2-negli-usa/ 2026-09-29T16:01:52.432Z weekly 0.7 https://agenfarma.it/punture-di-zecca-artemisia-lab-non-aspettare-gli-esami-in-presenza-di-sintomi/ 2026-09-27T14:36:17.029Z weekly 0.7 https://agenfarma.it/congo-ebola-non-rallenta-oltre-3-600-vittime-dall-inizio-dell-emergenza/ 2026-09-24T13:21:25.585Z weekly 0.7 https://agenfarma.it/morbillo-scatta-l-allarme-in-italia-ricoverati-con-gravi-complicanze-bassetti/ 2026-09-24T07:41:16.024Z weekly 0.7 https://agenfarma.it/sanita-med-salute-2026-quintavalle-porta-il-mezzogiorno-al-centro-della-sfida/ 2026-09-23T15:23:13.531Z weekly 0.7 https://agenfarma.it/prevenzione-artemisia-lab-apre-un-mese-di-iniziative-tra-senologia-e-geriatria/ 2026-09-23T09:06:03.455Z weekly 0.7 https://agenfarma.it/sanita-aran-accelera-sul-rinnovo-contratto-verso-la-chiusura-entro-ottobre/ 2026-09-22T14:33:10.692Z weekly 0.7 https://agenfarma.it/medici-veterinari-nel-privato-resta-il-vuoto-di-un-contratto-specifico/ 2026-09-22T12:49:26.614Z weekly 0.7 https://agenfarma.it/da-udine-a-monza-la-staffetta-della-fiaso-run-appuntamento-nel-2027-al-san-gerardo/ 2026-09-21T09:23:33.685Z weekly 0.7 https://agenfarma.it/professionisti-della-salute-il-rinnovo-prende-forma-nuove-garanzie-e-percorsi/ 2026-09-21T07:12:48.135Z weekly 0.7 https://agenfarma.it/scuola-e-salute-mentale-cangini-l-adolescenza-e-una-fase-delicata-serve/ 2026-09-19T11:10:14.349Z weekly 0.7 https://agenfarma.it/rogo-laurentina-commissione-ecomafie-apre-indagine-restano-rischi-per-la-salute/ 2026-09-17T10:16:07.926Z weekly 0.7 https://agenfarma.it/ue-kids-act-nuove-regole-per-proteggere-i-minori-online/ 2026-09-17T09:20:16.223Z weekly 0.7 https://agenfarma.it/farmacisti-nuove-regole-contrattuali-fino-2029/ 2026-09-17T08:53:33.035Z weekly 0.7 https://agenfarma.it/migranti-salvini-chiede-sanzioni-per-sanitari-sotto-accusa/ 2026-09-16T12:19:47.080Z weekly 0.7 https://agenfarma.it/sanita-uap-lancia-l-allarme-nuove-tariffe-insostenibili-rischio-blocco-VVsiV/ 2026-09-09T12:20:21.348Z weekly 0.7 https://agenfarma.it/sanita-privata-accreditata-confapi-salute-puglia-al-fianco-di-uap-dalla-14WoS/ 2026-09-07T15:36:05.949Z weekly 0.7 https://agenfarma.it/sanita-l-uap-chiama-a-raccolta-politica-e-istituzioni-tariffe-ferme-da-anni-dT7TH/ 2026-09-07T13:38:05.640Z weekly 0.7 https://agenfarma.it/neurochirurgia-prima-operazione-con-l-assistenza-dell-ia-rimossa-una-neoplasia-REmDa/ 2026-08-30T08:01:06.384Z weekly 0.7